CYTOSORBENTS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
CYTOSORBENTS CORPORATION (CTSO) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 8.81 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 8.81M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 8.76M shares.
- 2015-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.62M shares.
- 2015-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.71M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2026-06-30 | 8.81M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 8.76M shares 10-Q · filed 2026-05-13 |
| 2015-09-30 | 1.62M shares 10-Q · filed 2015-11-13 |
| 2015-06-30 | 1.71M shares 10-Q · filed 2015-08-13 |
| 2014-12-31 | 1.43M shares 10-K · filed 2015-03-31 |
| 2014-09-30 | 2.47M shares 10-Q · filed 2014-11-12 |
| 2014-06-30 | 1.62M shares 10-Q · filed 2014-08-12 |
| 2014-03-31 | 1.44M shares 10-Q · filed 2014-05-14 |
| 2013-12-31 | 34.51M shares 10-K · filed 2014-03-31 |
| 2012-12-31 | 29.27K shares 10-K · filed 2013-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |